Sangamo Therapeutics (SGMOQ) Minority Interest (2018 - 2021)

Sangamo Therapeutics' Minority Interest history runs 4 years deep, the most recent figure standing at -$938000.0 for Q1 2021.

• On a quarterly basis, Minority Interest fell 856.45% year-over-year to -$938000.0 in Q1 2021; TTM through Mar 2021 was -$938000.0, a 856.45% decrease from a year earlier, with the FY2020 full-year figure at -$868000.0, down 569.19% from the prior year.
• Minority Interest declined to -$938000.0 in Q1 2021 per SGMOQ's latest filing, from -$868000.0 in the prior quarter.
• Across five years, Minority Interest topped out at $739000.0 in Q4 2018 and bottomed at -$938000.0 in Q1 2021.
• The 4-year median for Minority Interest is $154500.0 (2019), against an average of $0.0.
• Across the five-year window, Minority Interest sank 74.97% in 2019 and plunged 856.45% in 2021, its largest moves.
• Year by year, Minority Interest stood at $739000.0 in 2018, then sank by 74.97% to $185000.0 in 2019, then plunged by 569.19% to -$868000.0 in 2020, then slipped by 8.06% to -$938000.0 in 2021.
• Per Business Quant, the three latest SGMOQ Minority Interest figures stand at -$938000.0 (Q1 2021), -$868000.0 (Q4 2020), and -$530000.0 (Q3 2020).